Mingwood Biotechnology Beijing, Ltd

Our business consists of three parts: diagnosis for women and children, mass spectrum, and orthopedics. In 2000, we began as a manufacturer of in-vitro diagnostic products, creating the BV Rapid Blue TM test reagent for gynecology, which became the first product of its kind to receive approval in China. Over time, we expanded our product line to include HPV, TCT, prenatal diagnosis, newborn screening, and other offerings. Additionally, we have built a robust national sales network for orthopedic products as a distributor. Our company is known for delivering high-quality trauma, joint, and spine implants and consumables to some of the...

Bv rapid blue tm,hpv,tct,prenatal diagnosis,newborn screening,trauma implants,joint implants,spine implants,and mass spectrum test

Mingwood biotechnology beijing, ltd operates in the Medical equipment manufacturing industry.

Mingwood biotechnology beijing, ltd's revenue is 11m - 100m

Mingwood biotechnology beijing, ltd has 11 - 50 employees.